Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children

Area of Science:

• Nephrology
• Biomarker Discovery
• Pediatric Dialysis

Background:

• Peritoneal dialysis (PD) is the preferred renal replacement therapy for pediatric end-stage kidney disease due to its advantages over hemodialysis (HD).
• Long-term PD use can lead to peritoneal membrane complications, primarily driven by chronic inflammation, potentially causing PD failure.
• Understanding the pathogenic pathways of peritoneal membrane alterations is crucial for improving patient outcomes.

Purpose of the Study:

• To review current research on proteomic analysis of peritoneal fluids and extracellular vesicles.
• To explore the potential of these analyses for identifying novel biomarkers in pediatric PD patients.
• To discuss how biomarker discovery can lead to personalized interventions and improved clinical outcomes.

Main Methods:

• Review of experimental and clinical studies on proteomic analysis in PD.
• Analysis of peritoneal fluids and extracellular vesicles for potential biomarkers.
• Focus on pediatric PD patient populations.

Main Results:

• Chronic inflammation significantly impacts peritoneal membrane structure and function, leading to sclerosis and PD failure.
• Proteomic analysis of peritoneal fluids and extracellular vesicles shows promise for identifying biomarkers.
• Biomarkers could aid in early detection of complications and personalized treatment strategies.

Conclusions:

• Proteomic analysis of peritoneal fluids and extracellular vesicles represents a promising avenue for biomarker discovery in pediatric PD.
• Identifying high-risk patients and implementing personalized interventions can improve the long-term outcomes of pediatric PD.
• Further research into these mechanisms is essential for advancing the care of children undergoing PD.